Open tender · Germany · Pharmaceutical products
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Peginterferon beta-1a (L03AB13) im Rahmen eines sogenannten Open-House-Modells
In EnglishConclusion of non-exclusive discount agreements pursuant to Sections 130a para. 8 / 130c para. 1 SGB V for pharmaceutical products containing the active ingredient peginterferon beta-1a (L03AB13) within the framework of a so-called open-house model
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse in Germany is inviting bids for “Conclusion of non-exclusive discount agreements pursuant to Sections 130a para. 8 / 130c para”. Bids close on 30 November 2026, 23:59 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Conclusion of non-exclusive discount contracts for the medicinal product Peginterferon beta-1a (L03AB13) under an Open-House model from 01.02.2025 to 31.01.2027.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 6 requirements to qualify (1 on experience, 5 certifications and registrations) and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences